摘要 |
This invention relates to the treatment of benign prostatic hyperplasia (BPH) using tocotrienols. Specifically, this invention relates to compositions and the use of compositions comprising individual tocotrienols, mixtures of tocotrienols and mixtures of one or more tocotrienols with other anti-BPH substances. |